Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
deals
fda
8
×
investing
8
×
life sciences
national blog main
san francisco blog main
8
×
boston top stories
national top stories
san francisco top stories
cancer immunotherapy
clinical trials
national
new york blog main
new york top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
europe blog main
europe top stories
indiana blog main
indiana top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
amag pharmaceuticals
arch venture partners
autoimmune diseases
What
bio
roundup
cancer
develop
amid
bombast
caught
coronavirus
days
debate
discussion
drug
efforts
fda
ipo
life
medicines
meso’s
millions
miss
new
pandemic
pfizer’s
presidential
promise
raised
response
science
therapeutics
treat
tuesday’s
vaccine
viewers
affects
alliance
americans
analytics
approval
approved
arrival
Language
unset
8
×
Current search:
investing
×
unset
×
fda
×
" san francisco blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds